Skinbac
Probiotical - Linkedin Probiotical - E-mail

Lacticaseibacillus rhamnosus LR06 (DSM 21981) (formerly Lactobacillus rhamnosus)

Single strain
Single strain
Home / Our Products / Strains and Blends
← Back to research page
On this page

Gastroenterology

GUT & ORAL DYSBIOSIS

Functionality

Inhibits a range of pathogens [in vitro]

Available Formats

Single strain

Blend

Finished dosage form

Scientific Support
In vitro studies

a) Mogna L. et al. Assessment of the In Vitro Inhibitory Activity of Specific Probiotic Bacteria Against Different Escherichia coli strains. J. Clin. Gastroenterol. 2012;46 Suppl.S29-32.  Doi: 10.1097/MCG.0b013e31826852b7

b) Deidda F, et al. How Probiotics may Kill Harmful Bacteria: The in vitro Activity against Some Haemolytic Strains. J Prob Health, 2020. Vol. 8 Iss.2 No: 216.  DOI: 10.35248/2329-8901.20.8.216

c) Squarzanti DF, et al. Il surnatante di Lactobacillus johnsonii LJO02 coltivato in un terreno vegetale contrasta la virulenza del patogeno opportunista Staphylococcus aureus. Poster from the XIX CONGRESSONAZIONALE CSID, held in Novara on 1-2 October, 2022

For information on blends containing LR06 see the following Blends pages:

  • GASTROBARRIER®
  • LR06 + LDD01 + LPS01 + LP01
  • Bifizen®
  • PROBIAL® Vision Dry
  • ALITOLACTIS®

Neurology

Gut-Brain Axis

Functionality

May support GI physiology for neurological health through the gut-brain axis [in vitro]

Available Formats

Blend

Finished dosage form

Scientific Support
In vitro studies

a) Visciglia A., et al. Probiotics and Gut-Brain Axis: Insights on local and systemic mechanisms of action. Poster from the 12th Probiotics, Prebiotics & New Foods, Nutraceutical and Botanicals for Nutrition & Human and Microbiota Health, held in Rome on 12-14 September 2021.

For information on blends containing LR06 see the following Blends pages:

  • GASTROBARRIER®
  • LR06 + LDD01 + LPS01 + LP01
  • Bifizen®
  • PROBIAL® Vision Dry
  • ALITOLACTIS®

Neurology

NEURO-IMMUNE HEALTH

Functionality

May support a healthy immune response in cells of patients with Parkinson’s Disease [in vitro]

Available Formats

Single strain

Blend

Finished dosage form

Scientific Support
In vitro studies

a) Magistrelli L.  et al. Probiotics May Have Beneficial Effects in Parkinson's Disease: In vitro Evidence. Front Immunol. 2019 May 7;10:969. doi: 10.3389/fimmu.2019.00969 

For information on blends containing LR06 see the following Blends pages:

  • GASTROBARRIER®
  • LR06 + LDD01 + LPS01 + LP01
  • Bifizen®
  • PROBIAL® Vision Dry
  • ALITOLACTIS®

Urology

URINARY TRACT HEALTH

Functionality

Inhibits pathogenic E. coli [in vitro] the primary cause of UTI and cystitis

Available Formats

Blend

Finished dosage form

Scientific Support
In vitro studies

a) Mogna L. et al. Assessment of the In Vitro Inhibitory Activity of Specific Probiotic Bacteria Against Different Escherichia coli strains. J. Clin. Gastroenterol. 2012;46 Suppl.S29-32.  Doi: 10.1097/MCG.0b013e31826852b7

For information on blends containing LR06 see the following Blends pages:

  • GASTROBARRIER®
  • LR06 + LDD01 + LPS01 + LP01
  • Bifizen®
  • PROBIAL® Vision Dry
  • ALITOLACTIS®

Associations